Business Description
HLB Science Inc
ISIN : KR7343090007
Share Class Description:
XKRX:343090: Ordinary SharesCompare
Compare
Traded in other countries / regions
343090.Korea IPO Date
2020-04-24Description
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.75 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.68 | |||||
Debt-to-EBITDA | -0.7 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.22 | |||||
9-Day RSI | 44.79 | |||||
14-Day RSI | 46.74 | |||||
6-1 Month Momentum % | -9.47 | |||||
12-1 Month Momentum % | 18.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.1 | |||||
Quick Ratio | 6.1 | |||||
Cash Ratio | 5.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -61.02 | |||||
ROIC % | -47.81 | |||||
ROC (Joel Greenblatt) % | -852.19 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PB Ratio | 22.25 | |||||
Price-to-Tangible-Book | 29.1 | |||||
EV-to-EBIT | -18.45 | |||||
EV-to-EBITDA | -21.46 | |||||
EV-to-FCF | -11.74 | |||||
Price-to-Net-Current-Asset-Value | 45.28 | |||||
Price-to-Net-Cash | 50.31 | |||||
Earnings Yield (Greenblatt) % | -5.42 | |||||
FCF Yield % | -8.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB Science Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | |||
EPS (TTM) (â‚©) | -205 | ||
Beta | 1.28 | ||
Volatility % | 113.64 | ||
14-Day RSI | 46.74 | ||
14-Day ATR (â‚©) | 133.476289 | ||
20-Day SMA (â‚©) | 2229.25 | ||
12-1 Month Momentum % | 18.85 | ||
52-Week Range (â‚©) | 1457 - 6600 | ||
Shares Outstanding (Mil) | 16.32 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HLB Science Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HLB Science Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
HLB Science Inc Frequently Asked Questions
What is HLB Science Inc(XKRX:343090)'s stock price today?
The current price of XKRX:343090 is â‚©2210.00. The 52 week high of XKRX:343090 is â‚©6600.00 and 52 week low is â‚©1457.00.
When is next earnings date of HLB Science Inc(XKRX:343090)?
The next earnings date of HLB Science Inc(XKRX:343090) is .
Does HLB Science Inc(XKRX:343090) pay dividends? If so, how much?
HLB Science Inc(XKRX:343090) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |